CLINICAL CHARACTERISTICS AND RENAL RISK OF PATIENTS WITH CHRONIC KIDNEY DISEASE: REAL-WORLD EVIDENCE FROM THE ICAREME GLOBAL REGISTRY

被引：0
|
作者：
Arici, Mustafa [1 ]
Pollock, Carol [2 ]
Goncalves, Susana [3 ]
Vasnawala, Hardik [4 ]
Hadaoui, Ahmed [5 ]
机构：
[1] Hacettepe Univ, Fac Med, Dept Nephrol, Ankara, Turkiye
[2] Univ Sydney, Royal North Shore Hosp, Kolling Inst, Camperdown, NSW, Australia
[3] AstraZeneca Int, Med Affairs, Buenos Aires, Argentina
[4] AstraZeneca Int, Med Affairs, Bengaluru, India
[5] AstraZeneca Algeria, Med Affairs, Buenos Aires, Argentina
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
6054
引用
收藏
页码：I544 / I545
页数：2
相关论文
共 50 条
  • [1] Clinical Characteristics and Management of Patients with Heart Failure in Egypt: Real-world Insights from iCaReMe Global Registry
    Zarif, Bassem
    Elgendy, Khaled
    Louis, Osama
    Enen, Mohamed
    Aboutaleb, Ahmed
    Samy, Eman
    Hassanein, Abdelrahman
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2024, 26 : V2 - V2
  • [2] Management of type 2 diabetes in chronic kidney disease: Insights from iCaReMe Global Registry
    Joshi, S.
    Pollock, C.
    Nicolucci, A.
    Fenici, P.
    Goncalves, S.
    Pentakota, S.
    Vasnawala, H.
    Hadaoui, A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
  • [3] Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease
    Folkerts, Kerstin
    Millier, Aurelie
    Smela, Beata
    Olewinska, Elzbieta
    Schmedt, Niklas
    Mernagh, Paul
    Kovesdy, Csaba P.
    JOURNAL OF NEPHROLOGY, 2023, 36 (04) : 1135 - 1167
  • [4] Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease
    Kerstin Folkerts
    Aurelie Millier
    Beata Smela
    Elzbieta Olewinska
    Niklas Schmedt
    Paul Mernagh
    Csaba P. Kovesdy
    Journal of Nephrology, 2023, 36 : 1135 - 1167
  • [5] Worsening of kidney function in patients with atrial fibrillation and chronic kidney disease: evidence from the real-world CALLIPER study
    Vaitsiakhovich, Tatsiana
    Coleman, Craig, I
    Kleinjung, Frank
    Vardar, Burcu
    Schaefer, Bernhard
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (06) : 937 - 945
  • [6] FEASIBILITY OF IDENTIFYING DEMOGRAPHIC AND CLINICAL INSIGHTS FOR PATIENTS WITH CHRONIC KIDNEY DISEASE FROM REAL-WORLD DATA
    Madaj, K.
    Brauneis, J.
    Menon, J.
    Vossen, C.
    VALUE IN HEALTH, 2024, 27 (06) : S392 - S392
  • [7] Baseline Characteristics and Real-world Treatment Patterns in People with T2D in India: Results from iCaReMe Registry
    Saboo, B.
    Kadam, Y.
    Vasnawala, H.
    Bharath, H.
    Sarda, S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [8] Use of antibiotics in patients with chronic kidney disease: evidence from the real world
    Valladales-Restrepo, Luis Fernando
    Henao-Salazar, Jairo Alejandro
    Mejia-Mejia, Isabel
    Castro-Aragon, David Arturo
    Rodriguez-Correa, Neiro
    Oyuela-Gutierrez, Maria Camila
    Calvo-Salazar, Juliana
    Osorio-Bustamante, Daniel
    Sabogal-Ortiz, Alejandra
    Machado-Alba, Jorge Enrique
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [9] Baseline characteristics of patients treated with vedolizumab in Taiwan: real-world evidence from TSIBD registry
    Lin, Wei-Chen
    Chang, Chung-Hsin
    Tu, Chia-Hung
    Feng, I-Che
    Chou, Jen-Wei
    Chung, Chen-Shuan
    Shieh, Ming-Jium
    Yen, Hsu-Heng
    Liu, Yuh-Hwa
    Tai, Wei-Chen
    Wu, Deng-Chyang
    Hsu, Wen-Hung
    Lu, Chien-Yu
    Lu, Lung-Sheng
    Tsai, Tzung-Jiun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 304 - 305
  • [10] Chronic kidney disease and hepatitis C mutually advance liver and renal disease progression: real-world evidence from the United States
    Tran, Tram T.
    Sanchez, Yuri
    Hayes, Oscar A.
    Marx, Steven
    HEPATOLOGY, 2017, 66 : 467A - 467A
12345